PT96332A - Processo de preparacao de novos derivados de xantina, dos seus intermediarios e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de novos derivados de xantina, dos seus intermediarios e de composicoes farmaceuticas que os contem

Info

Publication number
PT96332A
PT96332A PT96332A PT9633290A PT96332A PT 96332 A PT96332 A PT 96332A PT 96332 A PT96332 A PT 96332A PT 9633290 A PT9633290 A PT 9633290A PT 96332 A PT96332 A PT 96332A
Authority
PT
Portugal
Prior art keywords
treating
formamide
excess
compounds
making
Prior art date
Application number
PT96332A
Other languages
English (en)
Other versions
PT96332B (pt
Inventor
Armando Vega Noverola
Jose Manuel Prieto Soto
Jacinto Moragues Mauri
Robert W Gristwood
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of PT96332A publication Critical patent/PT96332A/pt
Publication of PT96332B publication Critical patent/PT96332B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Peptides Or Proteins (AREA)
PT96332A 1989-12-27 1990-12-21 Processo de preparacao de novos derivados de xantina, dos seus intermediarios e de composicoes farmaceuticas que os contem PT96332B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929208A GB8929208D0 (en) 1989-12-27 1989-12-27 New xanthine derivatives

Publications (2)

Publication Number Publication Date
PT96332A true PT96332A (pt) 1991-09-30
PT96332B PT96332B (pt) 1998-06-30

Family

ID=10668520

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96332A PT96332B (pt) 1989-12-27 1990-12-21 Processo de preparacao de novos derivados de xantina, dos seus intermediarios e de composicoes farmaceuticas que os contem

Country Status (30)

Country Link
US (1) US5223504A (pt)
EP (1) EP0435811B1 (pt)
JP (1) JPH089617B2 (pt)
KR (1) KR970001528B1 (pt)
CN (1) CN1029967C (pt)
AT (1) ATE93860T1 (pt)
AU (1) AU635104B2 (pt)
BR (1) BR9007258A (pt)
CA (1) CA2045478C (pt)
CZ (1) CZ278328B6 (pt)
DE (1) DE69003087T2 (pt)
DK (1) DK0435811T3 (pt)
EG (1) EG19436A (pt)
ES (1) ES2058864T3 (pt)
FI (1) FI96207C (pt)
GB (1) GB8929208D0 (pt)
HU (2) HU208825B (pt)
IE (1) IE64065B1 (pt)
IL (1) IL96708A (pt)
MX (1) MX23884A (pt)
MY (1) MY105303A (pt)
NO (1) NO178111C (pt)
NZ (1) NZ236517A (pt)
PL (1) PL166152B1 (pt)
PT (1) PT96332B (pt)
RU (1) RU2073679C1 (pt)
SK (1) SK278365B6 (pt)
UA (1) UA32512C2 (pt)
WO (1) WO1991009859A1 (pt)
ZA (1) ZA9010240B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521315A (en) * 1993-01-12 1996-05-28 Cell Therapeutics, Inc. Olefin substituted long chain compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247116T1 (de) 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
CA2218548A1 (en) * 1995-05-19 1996-11-21 Chiroscience Limited Xanthines and their therapeutic use
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
WO1998019672A1 (en) * 1996-11-01 1998-05-14 Nitromed Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US5874437A (en) * 1996-11-01 1999-02-23 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) * 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
GB9623859D0 (en) * 1996-11-15 1997-01-08 Chiroscience Ltd Novel compounds
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
ATE277616T1 (de) * 1999-05-04 2004-10-15 Altana Pharma Ag Synergistische kombination von roflumilast und pde-3 hemmern
EA006685B1 (ru) 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
EP2258689A1 (en) * 2000-03-16 2010-12-08 Biolipox AB Benzylated PDE4 inhibitors
EP1389468A4 (en) * 2001-05-23 2007-01-10 Tanabe Seiyaku Co COMPOSITIONS PROMOTING THE GUISON OF A BONE FRACTURE
CN1537018A (zh) * 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
AR115689A1 (es) 2018-07-05 2021-02-17 Sumitomo Chemical Co Compuestos de uracilo y su utilización
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
CH629788A5 (de) * 1977-07-20 1982-05-14 Lonza Ag Verfahren zur herstellung von 5,6-diaminouracil.
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds

Also Published As

Publication number Publication date
NO178111C (no) 1996-01-24
JPH089617B2 (ja) 1996-01-31
IL96708A (en) 1994-06-24
HU208825B (en) 1994-01-28
FI914014A0 (fi) 1991-08-26
ES2058864T3 (es) 1994-11-01
HUT57766A (en) 1991-12-30
IE64065B1 (en) 1995-07-12
RU2073679C1 (ru) 1997-02-20
MX23884A (es) 1993-09-01
DK0435811T3 (da) 1993-11-01
KR920701207A (ko) 1992-08-11
MY105303A (en) 1994-09-30
EG19436A (en) 1995-02-28
NO913236L (no) 1991-08-19
NZ236517A (en) 1992-09-25
SK278365B6 (en) 1997-01-08
FI96207B (fi) 1996-02-15
PT96332B (pt) 1998-06-30
BR9007258A (pt) 1992-02-25
NO913236D0 (no) 1991-08-19
IL96708A0 (en) 1991-09-16
EP0435811A1 (en) 1991-07-03
CZ278328B6 (en) 1993-11-17
CA2045478A1 (en) 1991-06-28
ATE93860T1 (de) 1993-09-15
UA32512C2 (uk) 2001-02-15
DE69003087T2 (de) 1993-12-16
ZA9010240B (en) 1991-10-30
US5223504A (en) 1993-06-29
GB8929208D0 (en) 1990-02-28
AU635104B2 (en) 1993-03-11
NO178111B (no) 1995-10-16
HU211573A9 (en) 1995-12-28
IE904634A1 (en) 1991-07-17
CN1052858A (zh) 1991-07-10
DE69003087D1 (de) 1993-10-07
EP0435811B1 (en) 1993-09-01
AU6976891A (en) 1991-07-24
CA2045478C (en) 1998-12-29
WO1991009859A1 (en) 1991-07-11
CN1029967C (zh) 1995-10-11
FI96207C (fi) 1996-05-27
KR970001528B1 (ko) 1997-02-11
JPH05500226A (ja) 1993-01-21
PL166152B1 (en) 1995-04-28

Similar Documents

Publication Publication Date Title
PT96332A (pt) Processo de preparacao de novos derivados de xantina, dos seus intermediarios e de composicoes farmaceuticas que os contem
WO1991013055A3 (en) New aryl- and heteroarylethenylene derivatives and process for their preparation
FI913815A (fi) Sulfonamidderivat.
ES2092603T3 (es) Procedimiento para la preparacion de piranonas y pirandionas.
PT89769A (pt) Processo para a preparacao de derivados do acido 3-alcenil-1-azabiciclo-{3,2,0}hept-2-eno-2-carboxilico
KR850002827A (ko) 2-(2-치환 벤조일)-1,3-시클로헥산디온의 제법
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
AU6747687A (en) New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them
JPS562968A (en) Novel pyrimidine derivative
PT81371B (pt) Processo para a preparacao de derivados de indano
ES8704486A1 (es) Procedimiento de preparar derivados rodaninicos.
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions
PT91880A (pt) Processo para a preparacao de derivados ariloxi-,ariltio-,heteroariloxi- ou heteroariltio-alcenilenicos de aminas e de composicoes farmaceuticas que os contem
US4179509A (en) (Substituted 2-carboxyanilino)nicotinic acids as inhibitors of allergic reactions
TH11134EX (th) อนุพันธ์ชนิดใหม่ของแซนธิน
JPS5620577A (en) 4- n-alkylanilino quinazoline derivative and its preparation
ES8704947A1 (es) Un procedimiento para preparar un derivado de imidazopirida-zina
GB1366319A (en) Sa 8-amino-theohylline derivatives process for their preparation and therapeutic compositon containing same
HUP9801983A2 (hu) Eljárás cisz-4-O-védett-2-ciklopentenol- és ciklopentanolszármazékok előállítására
TH14542EX (th) สารขัดขวางลูโคไทรอีนชนิดซับสทิทิวเทด เฟนิล ฟีนอล

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910509

FG3A Patent granted, date of granting

Effective date: 19980327

PC3A Transfer or assignment

Free format text: 19990729 ALMIRALL-PRODESFARMA, SOCIEDAD ANONIMA ES

PD3A Change of proprietorship

Owner name: GRUPO PLAFIN S.A.

Effective date: 19990729

TE3A Change of address (patent)

Owner name: GRUPO PLAFIN, S.A.

Effective date: 19990729

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080929